NYSE : GRDN

Guardian Pharmacy Services, Inc. — News

$39.975 USD

-$0.94 (-2.29%)

Volume
17.11K
Average Volume
416.64K
Market Capitalization
$2.53B
P/E Ratio
47.03
Dividend Yield
0.00%
Price Target
$43.50
Year High
$44.00
Year Low
$19.30
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.46
Source Headline
Bessemer Group Inc. Purchases Shares of 78,656 Guardian Pharmacy Services, Inc. $GRDN

Bessemer Group Inc. purchased a new stake in Guardian Pharmacy Services, Inc. (NYSE: GRDN) during the first quarter, according to its most recent 13F filing with the SEC. The firm purchased 78,656 shares of the company's stock, valued at approximately $2,962,000. Bessemer Group Inc. owned approximately 0.12% of Guardian Pharmacy Services as of

defenseworld.net - 2026-07-22 03:48:11

Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release second quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United.

businesswire.com - 2026-07-15 16:30:00

Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concepts, a long-term care pharmacy based in Grottoes, Virginia.

businesswire.com - 2026-07-01 16:30:00

Bet on Winning DuPont Analysis & Pick 5 Top Stocks

Do you have more faith in DuPont analysis than in simple ROE calculation? Tap CASY, ECG, GRDN, EXPD and MAMA for gains.

zacks.com - 2026-06-29 09:06:11

Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?

Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

zacks.com - 2026-06-29 06:56:06

Guardian Pharmacy Services, Inc. Announces Leadership Transitions

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since 2004, has decided to retire, effective as of July 1, 2026. Upon Mr. Forbes's retirement, David Morris, currently Executive Vice President and Chief Financial Officer of Guardian will assume the role of Chief Operating Officer. In connection with Mr. Morris' new role, Will Mudd, Senior Vice President, Finance, has b.

businesswire.com - 2026-06-22 16:30:00

Guardian Pharmacy Services, Inc. (GRDN) Hit a 52 Week High, Can the Run Continue?

Guardian Pharmacy (GRDN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

zacks.com - 2026-06-08 10:16:06

Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-13 14:00:46

Guardian Pharmacy Services Q1 Earnings Call Highlights

Guardian Pharmacy Services NYSE: GRDN reported what executives described as a solid first quarter of 2026, with management saying the company successfully navigated the initial implementation of the Inflation Reduction Act's new framework while maintaining its full-year revenue outlook and raising adjusted EBITDA guidance.

marketbeat.com - 2026-05-10 13:15:48

Guardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates

Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.

zacks.com - 2026-05-06 22:45:45

Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript

Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-06 19:51:13

Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the first quarter ended March 31, 2026. The Company also updated its full-year guidance. First Quarter Financial Results Revenue of $336.6 million, up 2% year-over-year. Residents served ended the quarter at approximately 207,000, up 10% year-over-year. Net Income of $13.5 million, compared to $9.3 mill.

businesswire.com - 2026-05-06 16:05:00

Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth

Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-30 11:01:27

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Recommendation of “Buy” by Analysts

Shares of Guardian Pharmacy Services, Inc. (NYSE: GRDN - Get Free Report) have been given an average recommendation of "Buy" by the eight analysts that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy

defenseworld.net - 2026-04-24 04:22:58

Guardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) will be attending the Bank of America 2026 Healthcare Conference in Las Vegas on Wednesday, May 13, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 9:20 a.m. Pacific Daylight Time. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation accessible through Guardian Pharmacy Service's website at https://i.

businesswire.com - 2026-04-23 17:00:00

Get GRDN Insider Trade Alerts

GRDN Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$47.00

1 analysts

Last Year

$36.43

7 analysts

All Time

$35.38

8 analysts

GRDN Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-06-17 Truist Securities Maintain Buy Buy
2026-06-17 B of A Securities Maintain Buy Buy
2026-05-07 Oppenheimer Maintain Outperform Outperform
2026-04-13 Truist Securities Maintain Buy Buy
2026-03-12 Truist Securities Maintain Buy Buy
2026-03-12 Oppenheimer Maintain Outperform Outperform
2026-01-14 Stephens & Co. Maintain Overweight Overweight